Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
Meet Our Postdocs
Postdoctoral scholars are vital to advancing disease-focused discovery at Gladstone. Working alongside lead investigators, they bring fresh perspectives and expertise that drive scientific breakthroughs and build the foundation for their future leadership.
Meet a few of our 100+ postdocs shaping the future of medicine through their unique backgrounds, scientific journeys, and drive to overcome disease.
Alicer Andrew
Roan Lab
Alicer Andrew, PhD, was one of the winners of UCSF’s 2024 Postdoc Slam award. She presented her research investigating how T cells respond to HIV infection. Read more about the award.
Alisa Dietl
Pelka and Marson Labs
Drawing on her experience as a physician, Alisa Dietl studies how the tumor microenvironment blocks killer T cells—and how engineered CAR T cells can be redesigned not only to attack cancer, but to deliver targeted therapies directly into tumors.
Rosmely Hernandez
Marson Lab
Rosmely Hernandez received an award from the Parker Institute for Cancer Immunotherapy to pursue innovative immunotherapy projects that could transform cancer treatment. Learn more about the award.
Shyam Jinagal
Srivastava Lab
Shyam Jinagal explores how genetics, aging, and regeneration shape the heart—and how those insights could one day restore heart function after injury.
Stephanie Miller
Palop Lab
Stephanie Miller and colleagues used machine learning to identify and categorize subtle behavioral patterns in mice that could indicate early cognitive decline. The technology could one day offer clinical value, perhaps enabling earlier diagnosis of patients with neurological disease. Learn more about this study.
Jason Nomburg
Doudna Lab Alumnus
Jason Nomburg, PhD, was part of a team that provided novel insights into nearly 70,000 lesser-known viral proteins that could eventually help in the development of new antiviral therapies. Learn more about the study.
Abdullah Syed
Doudna Lab Alumnus
Abdullah Syed and his colleagues used virus-like particles to understand how mutations that arose in SARS-CoV-2 altered the virus’ ability to spread and escape the immune system. Read more about this research.
Shijie Wang
Finkbeiner Lab
Shijie Wang, a postdoctoral scholar in Steve Finkbeiner’s lab, uses artificial intelligence, robotics, and stem cell technologies to uncover how brain cells die in neurodegenerative diseases like Alzheimer’s and Parkinson’s.
Marty Yang
Ramani Lab Alumnus
Marty Yang was part of a team that developed a new method to more fully understand DNA replication, a fundamental biological process that happens whenever cells in the body divide. Read more about the study.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
DONATE NOWLatest News
Read
In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Read
Gladstone Institutes Launches Redesigned Website, Bringing Cutting-Edge Biomedical Research Into Focus
Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
Read
Newly Discovered Antiviral System in Bacteria Is ‘Strangest of Its Kind’
The complex Rube Goldberg-like molecular machinery could inspire novel technology to study and treat disease.
Read
Gladstone’s Seth Shipman Named Fellow of the California Academy of Sciences
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
